Health risks associated with non-medical use of ketamine in France: National surveillance insights from the French Addictovigilance Network, 2019-2023.

J Psychopharmacol February 23, 2026 DOI: 10.1177/02698811261420018 (opens in new tab)

Study at a glance

AI-extracted from the abstract

Characteristics	Peer reviewed
Topics	Esketamine Ketamine

Abstract

Health risks associated with non-medical use of ketamine in France: National surveillance insights from the French Addictovigilance Network, 2019-2023.

Emerging new psychoactive ketamine analogues: patterns of use and health risks identified by the French Addictovigilance Network. The International journal on drug policy July 1, 2026
Trends in poisonings involving ketamine in the United States, 2019-2023. Drug and Alcohol Dependence March 1, 2025 9 citations
Ketamine-Related Deaths Registered in Scotland 2013–2024 Clinical Neuropsychopharmacology and Addiction January 4, 2026
Rising incidence of recreational ketamine use: Clinical cases and management in emergency settings. Toxicology Reports June 1, 2025 9 citations
The Rapidly Shifting Ketamine Landscape in the US JAMA Psychiatry January 3, 2024 41 citations

Study at a glance

Abstract

Related reading